IP Verse

Method For Preparing Active Form Of Tnfr-Fc Fusion Protein - EP2753634

The patent EP2753634 was granted to Ares Trading on Nov 1, 2017. The application was originally filed on Aug 17, 2012 under application number EP12823797A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2753634

ARES TRADING
Application Number
EP12823797A
Filing Date
Aug 17, 2012
Status
Granted And Under Opposition
Sep 29, 2017
Grant Date
Nov 1, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DEHMEL & BETTENHAUSENJul 31, 2018RUCKERLWITHDRAWN

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO03072060
DESCRIPTIONWO2005042569
DESCRIPTIONWO2005075498
INTERNATIONAL-SEARCH-REPORTUS2005136521
OPPOSITIONUS2008076155
OPPOSITIONWO0036092
OPPOSITIONWO2005075498
OPPOSITIONWO2009111347
SEARCHWO03072060
SEARCHWO2005042569
SEARCHWO2005075498
SEARCHWO2009111347

Non-Patent Literature (NPL) Citations (11) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- "Hydrophobic Interaction and Reversed Phase Chromatography - Principles and Methods", (20060201), URL: http://wolfson.huji.ac.il/purification/PDF/HCIC/AMERSHAM_HIC_RPC.pdf, (20131125), XP055090096-
INTERNATIONAL-SEARCH-REPORT- MURRAY, K. M. ET AL., "RECOMBINANT HUMAN TUMOR NECROSIS FACTOR RECEPTOR (P75) FC FUSION PROTEIN (TNFR:FC) OM RHEUMATOID ARTHRITIS", THE ANNALS OF PHARMACOTHERAPY, (1997), vol. 31, no. 11, pages 1335 - 1338, XP000952552-
INTERNATIONAL-SEARCH-REPORT- ZOLODZ, M. D. ET AL., "Separation by hydrophobic interaction chromatography and structural determination by mass spectrometry of mannosylated glycoforms of a recombinant transferrin-exendin-4 fusion protein from yeast", JOURNAL OF CHROMATOGRAPHY A, (2010), vol. 1217, no. 2, pages 225 - 234, XP026817105-
INTERNATIONAL-SEARCH-REPORT- EVANS, D. R. H. ET AL., "Purification of an Fc-fusion biologic: Clearance of multiple product related impurities by hydrophobic interaction chromatography", JOURNAL OF CHROMATOGRAPHY A, (2008), vol. 1177, pages 265 - 271, XP022401694
INTERNATIONAL-SEARCH-REPORT- TIWARI, N. ET AL., "Identification and characterization of native proteins of Escherichia coli BL-21 that display affinity towards Immobilized Metal Affinity Chromatography and Hydrophobic Interaction Chromatography Matrices", PROTEIN EXPRESSIO AND PURIFICATION, (2010), vol. 70, pages 191 - 195, XP026915652
INTERNATIONAL-SEARCH-REPORT- KOHNO, T. ET AL., "Binding Characteristics of Tumor Necrosis Factor Receptor-Fc Fusion Proteins vs Anti-Tumor Necrosis Factor mAbs", J. INVESTIG. DERMATOL. SYMP PROC., (200705), vol. 12, no. 1, pages 5 - 8, XP055144570
INTERNATIONAL-SEARCH-REPORT- KYOGOKU, K. ET AL., "PRODUCTION OF RECOMBINANT TUMOR NECROSIS FACTOR RECEPTOR/FC FUSION PROTEIN BY GENETICALLY MANIPULATED CHICKEN", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, (2008), vol. 105, no. 5, pages 454 - 459, XP022733110
OPPOSITION- A. Shukla, Yinges Yigzaw, "6 - Modes of Preparative Chromatography", A. Shukla, Yinges Yigzaw, Shukla, A. et al., Process Scale Bioseparations for the Biopharmaceutical Industry, CRC Press, (20070000), pages 5pp, 179 - 225, XP055508081-
OPPOSITION- "Hydrophobic Interaction and Reversed Phase Chromatography - Principles and Methods", (20060201), URL: http://wolfson.huji.ac.il/purification/PDF/HCIC/AMERSHAM_HIC_RPC.pdf, XP055090096-
OPPOSITION- Evans; Macniven D R H; Labanca R P; Walker M; Notarnicola J; S M, "Purification of an Fc-fusion biologic: Clearance of multiple product related impurities by hydrophobic interaction chromatography", Journal of Chromatography A, (20080000), vol. 1177, no. 2, pages 265 - 271, XP022401694
SEARCH- EVANS ET AL, "Purification of an Fc-fusion biologic: Clearance of multiple product related impurities by hydrophobic interaction chromatography", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, (20071226), vol. 1177, no. 2, doi:10.1016/J.CHROMA.2007.07.049, ISSN 0021-9673, pages 265 - 271, XP022401694 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents